Project Grant K99NS146613
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded Columbia University's Health Sciences Division a Project Grant of $126,900 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective August 1, 2025, through July 31, 2027. This award supports computational research aimed at understanding multi-area neural circuit mechanisms underlying memory-guided movements, with direct...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded Columbia University's Health Sciences Division a Project Grant of $329,341 on July 18, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award funds a Postdoctoral T32 training program in Integrated Computational and Experimental Sensorimotor Control, designed to support 10 postdoctoral trainees over a five-year project...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded Columbia University's Health Sciences Division a $649,638 Project Grant effective August 1, 2025, through July 31, 2030, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award funds research focused on engineering alternative splicing programs to accelerate maturation of stem cell-derived neurons. The primary...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded Columbia University's Health Sciences Division a $644,965 Project Grant (CFDA 93.853: Extramural Research Programs in the Neurosciences and Neurological Disorders) effective February 1, 2026, through January 31, 2031. This research initiative investigates phylogenetic differences in motor neuron development between humans and mice using human induced pluripotent stem cell (hiPSC)...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Regents of the University of Colorado, doing business as University of Colorado-Denver, a Project Grant totaling $501,125 under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award, effective August 1, 2025, through July 31, 2030, supports a five-year investigator-initiated research project examining the modes of dopamine...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded a Project Grant of $185,042 to the University of Colorado-Denver on July 14, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. This research project, titled "The Role of Subsynaptic Nanoscale Architecture in Inhibitory Synaptic Plasticity," extends through November 30, 2027, and focuses on advancing fundamental...
- Federal Grant Award Summary New York University received a $527,037 Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award was obligated on June 12, 2025, with a project completion date of May 31, 2030. The research aims to elucidate the neural mechanisms that integrate cognitive decision-making with motor action by recording and...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded Harvard College $120,582 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program on January 17, 2026. This project grant supports fundamental neuroscience research investigating motor learning mechanisms within cortico-basal ganglia circuits. The research will employ advanced methodologies including machine vision-based three-dimensional...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded Columbia University's Health Sciences Division a Project Grant totaling $147,486 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective September 15, 2025, with completion targeted for September 30, 2026. The award funds investigator-initiated research examining the neural circuits underlying social evaluation in female zebra...
- Federal Grant Award Summary Harvard Medical School received a $130,932 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective May 1, 2025 through January 31, 2028. The award supports fundamental neuroscience research investigating the neural mechanisms underlying behavioral variability and strategy selection—specifically, how organisms...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded Columbia University's Health Sciences Division a $126,900 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program on January 16, 2026, with completion targeted for December 31, 2027. This award supports fundamental neuroscience research investigating the synaptic mechanisms underlying dopamine-driven reinforcement learning in the cerebral cortex. The research employs advanced in vivo imaging technologies, genetically encoded dopamine sensors, optogenetics, and brain-machine interface (BMI) paradigms to characterize how dopamine-dependent synaptic plasticity shapes neural circuits during learning and adaptive behavior. The funded research is structured across a mentored phase and an independent phase with three specific aims: (1) utilizing optical BMI combined with two-photon calcium imaging to characterize how dopamine-driven reinforcement learning reorganizes synaptic inputs onto cortical ensembles; (2) tracking functional synaptic activity during reinforcement learning to determine how dopamine alters synaptic strength and dynamics over time; and (3) mapping spatiotemporal dopamine release patterns and applying chemogenetic and pharmacological manipulations to assess the mechanisms of dopamine-driven synaptic plasticity in vivo. These investigations address a fundamental knowledge gap regarding precise synaptic mechanisms of dopamine-dependent plasticity and advance understanding of how the brain reinforces neural activity to drive learning.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 1/15/26 | ||
| Not listed | $126.9k | 1/14/26 |